J1456
HCPCSInj, fosaprepitant (teva)
Official HCPCS Level II long descriptor
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
HCPCS Level II code J1456 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, fosaprepitant (teva)
Added to HCPCS: 2023-01-01
Nearby codes in J1
- J1447Inj tbo filgrastim 1 microg
- J1448Injection, trilaciclib, 1mg
- J1449Inj eflapegrastim-xnst 0.1mg
- J1450Fluconazole
- J1451Fomepizole, 15 mg
- J1453Fosaprepitant injection
- J1454Inj fosnetupitant, palonoset
- J1455Foscarnet sodium injection
- J1458Galsulfase injection
- J1459Inj ivig privigen 500 mg
- J1460Gamma globulin 1 cc inj
- J1551Inj cutaquig 100 mg
- J1552Inj, alyglo, 500 mg
- J1553Inj yimmugo 100 mg
- J1554Inj. asceniv
- J1555Inj cuvitru, 100 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.